Literature DB >> 9468178

Acute lung injury and the acute respiratory distress syndrome.

J M Luce1.   

Abstract

OBJECTIVE: To review acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) in light of recent information about the definitions, epidemiology, pathophysiology, management, and outcome of these conditions. DATA SOURCES: The author's personal files as well as the computerized MEDLINE database. STUDY SOLUTION: Studies were selected for their relevance to the conditions of ALI and ARDS. DATA EXTRACTION: The author extracted all applicable data. DATA SYNTHESIS: The diagnostic criteria for ALI and ARDS include a) acute onset; b) bilateral chest radiographic infiltrates; c) a pulmonary artery occlusion pressure of < or =18 mm Hg or no evidence of left atrial hypertension; and d) impaired oxygenation manifested by a PaO2/FIO2 ratio of < or =300 torr (< or =40 kPa) for ALI and < or =200 torr (< or =27 kPa) for ARDS. The incidence of ALI and ARDS are approximately 70 and 7 patients out of 100,000 of the total U.S. population per year, respectively. The conditions result from direct or indirect injury to the pulmonary epithelium and endothelium that causes edema, atelectasis, inflammation, and fibrosis. This "diffuse alveolar damage" is actually patchy in many patients. Therapy of ALI and ARDS is largely supportive, although new approaches in mechanical ventilation, patient positioning, and pharmacologic therapy have been introduced. The mortality rate of ARDS has improved to <50%, but the reasons for this improvement are unclear.
CONCLUSION: ALI and ARDS are better defined and understood than ever before, and their outcome has improved for unclear reasons.

Entities:  

Mesh:

Year:  1998        PMID: 9468178     DOI: 10.1097/00003246-199802000-00043

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

Review 2.  Lung Contusion: A Clinico-Pathological Entity with Unpredictable Clinical Course.

Authors:  Farooq Ahmad Ganie; Hafeezulla Lone; Ghulam Nabi Lone; Mohd Lateef Wani; Shyam Singh; Abdual Majeed Dar; Nasir-U-Din Wani; Shadab Nabi Wani; Nadeem-Ul Nazeer
Journal:  Bull Emerg Trauma       Date:  2013-01

Review 3.  Diagnosis of pneumothorax in critically ill adults.

Authors:  J J Rankine; A N Thomas; D Fluechter
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

4.  miR-200b/c attenuates lipopolysaccharide-induced early pulmonary fibrosis by targeting ZEB1/2 via p38 MAPK and TGF-β/smad3 signaling pathways.

Authors:  Yongmei Cao; Yujing Liu; Feng Ping; Lyu Yi; Zhen Zeng; Yingchuan Li
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

5.  Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury.

Authors:  Joyce N Gonzales; Boris Gorshkov; Matthew N Varn; Marina A Zemskova; Evgeny A Zemskov; Supriya Sridhar; Rudolf Lucas; Alexander D Verin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-10       Impact factor: 5.464

6.  Quantifying the severity of acute lung injury using dead-space ventilation: should the lung injury score be updated?

Authors:  Richard H Kallet; James A Alonso; Michael A Matthay
Journal:  Respir Care       Date:  2012-03       Impact factor: 2.258

Review 7.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

8.  Fluid balance in critically ill children with acute lung injury.

Authors:  Stacey L Valentine; Anil Sapru; Renee A Higgerson; Phillip C Spinella; Heidi R Flori; Dionne A Graham; Molly Brett; Maureen Convery; LeeAnn M Christie; Laurie Karamessinis; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2012-10       Impact factor: 7.598

9.  The association between physiologic dead-space fraction and mortality in subjects with ARDS enrolled in a prospective multi-center clinical trial.

Authors:  Richard H Kallet; Hanjing Zhuo; Kathleen D Liu; Carolyn S Calfee; Michael A Matthay
Journal:  Respir Care       Date:  2013-12-31       Impact factor: 2.258

10.  CaMKIα regulates AMP kinase-dependent, TORC-1-independent autophagy during lipopolysaccharide-induced acute lung neutrophilic inflammation.

Authors:  Lanping Guo; Jennifer L Stripay; Xianghong Zhang; Richard D Collage; Mei Hulver; Evie H Carchman; Gina M Howell; Brian S Zuckerbraun; Janet S Lee; Matthew R Rosengart
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.